Document Detail


Distal deep venous thrombosis in a hemophilia A patient with inhibitor and severe infectious disease, 18 days after recombinant activated factor VII transfusion.
MedLine Citation:
PMID:  12032404     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We describe a 38 year old hemophilia A patient with a factor VIII inhibitor who was admitted to our Hematology Department in January 2001 with a seriously infected and bleeding perianal ulcer. To treat infection and bleeding the patient received broad spectrum antibiotics and recombinant activated factor VII (rFVIIa) (Novoseven(R)) for about 1 month (see detailed time of administration and dosing schedule of rFVIIa further in text). Eighteen days after his last rVIIa infusion the patient developed an ultrasound proven right calf vein thrombosis. In the whole period of admission, preceding the thrombotic event the patient biologically showed a picture of severe systemic inflammatory disease as indicated by persistent increased levels of D-dimer and fibrinogen (table). It is an interesting point of discussion whether the calf thrombosis was provoked as a consequence of rFVIIa infusion (with symptoms 18 days after the last infusion) or as a consequence of long-standing immobilization and severe inflammatory disease immobilization and severe infection are conditions well known for promoting venous thromboembolic disease.
Authors:
M G Van der Planken; W Schroyens; F Vertessen; J J Michiels; Z N Berneman
Related Documents :
23151224 - Not as transient: patients with transient ischaemic attack or minor stroke experience c...
23196534 - How to train stroke neurologists.
8725994 - Safety and efficacy of picotamide, a dual anti-thromboxane agent, in patients with thro...
22173814 - Off-label prescriptions for adult neurological patients: a pilot survey in china.
16036524 - Plasma acylated ghrelin levels correlate with subjective symptoms of functional dyspeps...
21236554 - Clinical evolution of patients with respiratory allergic disease due to sensitisation t...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis     Volume:  13     ISSN:  0957-5235     ISO Abbreviation:  Blood Coagul. Fibrinolysis     Publication Date:  2002 Jun 
Date Detail:
Created Date:  2002-05-28     Completed Date:  2003-07-11     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9102551     Medline TA:  Blood Coagul Fibrinolysis     Country:  England    
Other Details:
Languages:  eng     Pagination:  367-70     Citation Subset:  IM    
Affiliation:
Laboratory of Hematology and Hemostasis, Antwerp University Hospital, Edegem, Belgium. marc.van.der.planken@uza.be
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anti-Bacterial Agents / administration & dosage
Factor VII / administration & dosage,  adverse effects*
Factor VIIa
Hemophilia A / complications*,  drug therapy,  immunology
Humans
Immobilization / adverse effects
Infection / complications*,  drug therapy
Isoantibodies / blood
Male
Recombinant Proteins / administration & dosage,  adverse effects*
Venous Thrombosis / etiology*
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Isoantibodies; 0/Recombinant Proteins; 0/recombinant FVIIa; 9001-25-6/Factor VII; EC 3.4.21.21/Factor VIIa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acquired type 3-like von Willebrand syndrome preceded full-blown systemic lupus erythematosus.
Next Document:  Plasma nitrite/nitrate and erythropoietin levels in cross-country skiers during altitude training.